Shanghai Fosun Pharmaceutical Performance
| SFOSFDelisted Stock | USD 2.67 0.00 0.00% |
The entity has a beta of -1.1, which indicates a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Shanghai Fosun are expected to decrease slowly. On the other hand, during market turmoil, Shanghai Fosun is expected to outperform it slightly. Shanghai Fosun Pharm right now has a risk of 0.0%. Please validate Shanghai Fosun mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and day median price , to decide if Shanghai Fosun will be following its existing price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Shanghai Fosun Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Shanghai Fosun is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 7.3 B | |
| Total Cashflows From Investing Activities | -3.9 B |
Shanghai |
Shanghai Fosun Relative Risk vs. Return Landscape
If you would invest 267.00 in Shanghai Fosun Pharmaceutical on October 10, 2025 and sell it today you would earn a total of 0.00 from holding Shanghai Fosun Pharmaceutical or generate 0.0% return on investment over 90 days. Shanghai Fosun Pharmaceutical is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Shanghai, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Shanghai Fosun Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Shanghai Fosun's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Shanghai Fosun Pharmaceutical, and traders can use it to determine the average amount a Shanghai Fosun's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SFOSF |
Based on monthly moving average Shanghai Fosun is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Shanghai Fosun by adding Shanghai Fosun to a well-diversified portfolio.
Shanghai Fosun Fundamentals Growth
Shanghai Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Shanghai Fosun, and Shanghai Fosun fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Shanghai Pink Sheet performance.
| Return On Equity | 0.0756 | |||
| Return On Asset | 0.0204 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 15.52 B | |||
| Shares Outstanding | 551.94 M | |||
| Price To Earning | 13.80 X | |||
| Price To Book | 1.45 X | |||
| Price To Sales | 0.31 X | |||
| Revenue | 39.01 B | |||
| EBITDA | 8.71 B | |||
| Cash And Equivalents | 14.64 B | |||
| Cash Per Share | 5.49 X | |||
| Total Debt | 9.05 B | |||
| Debt To Equity | 0.64 % | |||
| Book Value Per Share | 16.30 X | |||
| Cash Flow From Operations | 3.95 B | |||
| Earnings Per Share | 0.21 X | |||
| Total Asset | 93.29 B | |||
| Retained Earnings | 10.37 B | |||
| Current Asset | 10.27 B | |||
| Current Liabilities | 11.09 B | |||
About Shanghai Fosun Performance
By analyzing Shanghai Fosun's fundamental ratios, stakeholders can gain valuable insights into Shanghai Fosun's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Shanghai Fosun has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Shanghai Fosun has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Shanghai Fosun Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. Shanghai Fosun Pharmaceutical Co., Ltd. was founded in 1994 and is based in Shanghai, China. Shanghai Fosun operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 36604 people.Things to note about Shanghai Fosun Pharm performance evaluation
Checking the ongoing alerts about Shanghai Fosun for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Shanghai Fosun Pharm help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Shanghai Fosun Pharm is not yet fully synchronised with the market data | |
| Shanghai Fosun Pharm has a very high chance of going through financial distress in the upcoming years |
- Analyzing Shanghai Fosun's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Shanghai Fosun's stock is overvalued or undervalued compared to its peers.
- Examining Shanghai Fosun's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Shanghai Fosun's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Shanghai Fosun's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Shanghai Fosun's pink sheet. These opinions can provide insight into Shanghai Fosun's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Shanghai Pink Sheet
If you are still planning to invest in Shanghai Fosun Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Shanghai Fosun's history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |